These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8588135)

  • 1. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
    Ortqvist A; Hedlund J; Wretlind B; Carlström A; Kalin M
    Scand J Infect Dis; 1995; 27(5):457-62. PubMed ID: 8588135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
    Alcoba G; Keitel K; Maspoli V; Lacroix L; Manzano S; Gehri M; Tabin R; Gervaix A; Galetto-Lacour A
    Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin in children admitted to hospital with community acquired pneumonia.
    Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
    Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
    Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
    Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia.
    Lieberman D; Livnat S; Schlaeffer F; Porath A; Horowitz S; Levy R
    Infection; 1997; 25(2):90-4. PubMed ID: 9108183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.
    Hedlund J; Hansson LO
    Infection; 2000; 28(2):68-73. PubMed ID: 10782390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens.
    Liu M; Li H; Xue CX; Gu L; Qu JX; Yu XM; Wang YM; Liu YM; Cao B
    Clin Respir J; 2018 Mar; 12(3):974-985. PubMed ID: 28139879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia.
    Burgmeijer EH; Duijkers R; Lutter R; Bonten MJM; Schweitzer VA; Boersma WG
    Clin Respir J; 2019 Oct; 13(10):605-613. PubMed ID: 31310442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker].
    Saldías-Peñafiel F; Salinas-Rossel G; Farcas-Oksenberg K; Reyes-Sánchez A; Díaz-Patiño O
    Rev Med Chil; 2019 Aug; 147(8):983-992. PubMed ID: 31859962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiological agents, interleukin-6, interleukin-8 and CRP concentrations in children with community- and hospital-acquired pneumonia.
    Tumgor G; Celik U; Alabaz D; Cetiner S; Yaman A; Yildizdas D; Alhan E
    Ann Trop Paediatr; 2006 Dec; 26(4):285-91. PubMed ID: 17132293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia.
    Amaro R; Liapikou A; Cilloniz C; Gabarrus A; Marco F; Sellares J; Polverino E; Garau J; Ferrer M; Musher DM; Torres A
    Eur Respir J; 2016 Sep; 48(3):797-807. PubMed ID: 27174880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings.
    Heiskanen-Kosma T; Korppi M
    Scand J Infect Dis; 2000; 32(4):399-402. PubMed ID: 10959648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients.
    Karhu J; Ala-Kokko TI; Vuorinen T; Ohtonen P; Julkunen I; Syrjälä HT
    Cytokine; 2019 Jan; 113():272-276. PubMed ID: 30055898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.